What Does Mandatory Portfolio Disclosure Reveal? A Placebo Test of the 13F Regime
This paper utilizes a placebo test involving Norges Bank's delayed disclosure of confidential positions to demonstrate that mandatory 13F portfolio disclosures do not significantly move stock prices, thereby challenging the premise that such disclosure imposes substantial market-moving costs.